Northern Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $466M | Sell |
5,824,369
-56,119
| -1% | -$4.63M | 0.06% | 268 |
|
|
2025
Q4 | $501M | Sell |
5,880,488
-160,157
| -3% | -$13.1M | 0.06% | 254 |
|
|
2025
Q3 | $470M | Sell |
6,040,645
-70,882
| -1% | -$5.54M | 0.06% | 273 |
|
|
2025
Q2 | $478M | Sell |
6,111,527
-136,690
| -2% | -$10.2M | 0.07% | 259 |
|
|
2025
Q1 | $453M | Sell |
6,248,217
-257,010
| -4% | -$18.4M | 0.07% | 267 |
|
|
2024
Q4 | $482M | Buy |
6,505,227
+1,165,845
| +22% | +$81.6M | 0.07% | 247 |
|
|
2024
Q3 | $352M | Sell |
5,339,382
-376,879
| -7% | -$27.4M | 0.06% | 292 |
|
|
2024
Q2 | $528M | Sell |
5,716,261
-49,100
| -0.9% | -$4.35M | 0.09% | 201 |
|
|
2024
Q1 | $551M | Sell |
5,765,361
-186,889
| -3% | -$15.7M | 0.1% | 203 |
|
|
2023
Q4 | $454M | Sell |
5,952,250
-405,223
| -6% | -$28.2M | 0.08% | 226 |
|
|
2023
Q3 | $440M | Buy |
6,357,473
+241,347
| +4% | +$19.4M | 0.09% | 216 |
|
|
2023
Q2 | $577M | Sell |
6,116,126
-434,642
| -7% | -$37.8M | 0.11% | 169 |
|
|
2023
Q1 | $542M | Buy |
6,550,768
+16,469
| +0.3% | +$1.29M | 0.11% | 184 |
|
|
2022
Q4 | $488M | Buy |
6,534,299
+34,664
| +0.5% | +$2.67M | 0.1% | 198 |
|
|
2022
Q3 | $537M | Sell |
6,499,635
-89,395
| -1% | -$8.6M | 0.12% | 159 |
|
|
2022
Q2 | $627M | Sell |
6,589,030
-152,687
| -2% | -$15.8M | 0.13% | 148 |
|
|
2022
Q1 | $794M | Sell |
6,741,717
-37,218
| -0.5% | -$4.18M | 0.14% | 138 |
|
|
2021
Q4 | $878M | Buy |
6,778,935
+12,042
| +0.2% | +$1.4M | 0.14% | 130 |
|
|
2021
Q3 | $766M | Buy |
6,766,893
+75,851
| +1% | +$8.66M | 0.14% | 133 |
|
|
2021
Q2 | $693M | Sell |
6,691,042
-95,426
| -1% | -$8.99M | 0.12% | 151 |
|
|
2021
Q1 | $568M | Sell |
6,786,468
-1,820
| -0% | -$154K | 0.11% | 173 |
|
|
2020
Q4 | $619M | Sell |
6,788,288
-270,042
| -4% | -$22.4M | 0.12% | 153 |
|
|
2020
Q3 | $563M | Sell |
7,058,330
-60,991
| -0.9% | -$4.76M | 0.12% | 157 |
|
|
2020
Q2 | $492M | Buy |
7,119,321
+91,074
| +1% | +$6.47M | 0.12% | 161 |
|
|
2020
Q1 | $442M | Sell |
7,028,247
-75,402
| -1% | -$5.44M | 0.13% | 157 |
|
|
2019
Q4 | $552M | Sell |
7,103,649
-34,500
| -0.5% | -$2.69M | 0.12% | 159 |
|
|
2019
Q3 | $523M | Sell |
7,138,149
-129,648
| -2% | -$9.11M | 0.13% | 163 |
|
|
2019
Q2 | $448M | Buy |
7,267,797
+146,793
| +2% | +$8.88M | 0.11% | 190 |
|
|
2019
Q1 | $454M | Buy |
7,121,004
+67,608
| +1% | +$3.86M | 0.11% | 180 |
|
|
2018
Q4 | $360M | Buy |
7,053,396
+226,173
| +3% | +$11.4M | 0.1% | 195 |
|
|
2018
Q3 | $396M | Sell |
6,827,223
-320,541
| -4% | -$15.7M | 0.1% | 201 |
|
|
2018
Q2 | $347M | Buy |
7,147,764
+1,713
| +0% | +$80K | 0.09% | 218 |
|
|
2018
Q1 | $332M | Sell |
7,146,051
-115,068
| -2% | -$5M | 0.09% | 230 |
|
|
2017
Q4 | $273M | Sell |
7,261,119
-98,310
| -1% | -$3.61M | 0.07% | 274 |
|
|
2017
Q3 | $268M | Buy |
7,359,429
+384,990
| +6% | +$14.7M | 0.07% | 275 |
|
|
2017
Q2 | $275M | Sell |
6,974,439
-231,387
| -3% | -$8.45M | 0.08% | 251 |
|
|
2017
Q1 | $226M | Sell |
7,205,826
-18,702
| -0.3% | -$586K | 0.07% | 292 |
|
|
2016
Q4 | $226M | Sell |
7,224,528
-636,312
| -8% | -$20.6M | 0.07% | 280 |
|
|
2016
Q3 | $316M | Buy |
7,860,840
+58,509
| +0.7% | +$2.2M | 0.1% | 206 |
|
|
2016
Q2 | $259M | Sell |
7,802,331
-75,330
| -1% | -$2.58M | 0.08% | 243 |
|
|
2016
Q1 | $246M | Buy |
7,877,661
+20,904
| +0.3% | +$577K | 0.08% | 246 |
|
|
2015
Q4 | $207M | Sell |
7,856,757
-535,521
| -6% | -$13.9M | 0.07% | 281 |
|
|
2015
Q3 | $199M | Sell |
8,392,278
-253,098
| -3% | -$6.11M | 0.07% | 287 |
|
|
2015
Q2 | $205M | Buy |
8,645,376
+260,604
| +3% | +$5.88M | 0.06% | 305 |
|
|
2015
Q1 | $199M | Sell |
8,384,772
-182,040
| -2% | -$4.08M | 0.06% | 317 |
|
|
2014
Q4 | $182M | Buy |
8,566,812
+50,778
| +0.6% | +$1.02M | 0.05% | 335 |
|
|
2014
Q3 | $145M | Sell |
8,516,034
-108,696
| -1% | -$1.72M | 0.05% | 370 |
|
|
2014
Q2 | $123M | Sell |
8,624,730
-714,792
| -8% | -$9.69M | 0.04% | 424 |
|
|
2014
Q1 | $115M | Buy |
9,339,522
+48,894
| +0.5% | +$564K | 0.04% | 442 |
|
|
2013
Q4 | $102M | Buy |
9,290,628
+186,816
| +2% | +$2.11M | 0.03% | 462 |
|
|
2013
Q3 | $106M | Sell |
9,103,812
-717,438
| -7% | -$8.39M | 0.04% | 424 |
|
|
2013
Q2 | $110M | Buy |
+9,821,250
| New | +$116M | 0.04% | 403 |
|
Other funds holding EW
VCM
VPM
Northern Trust's EW Position: Q1 2026 in Review
Northern Trust reduced its Edwards Lifesciences (EW) stake by 0.95% in Q1 2026, selling an estimated $4.63M and leaving 5,824,369 shares worth $466M. The position accounts for 0.06% of the portfolio, ranked #268.
Northern Trust first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $878M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Northern Trust held 5,824,369 shares of Edwards Lifesciences worth $466M as of Q1 2026.
- Northern Trust sold 56,119 Edwards Lifesciences shares in Q1 2026, an estimated $4.63M.
- Edwards Lifesciences made up 0.06% of Northern Trust's portfolio in Q1 2026, its #268 holding.
- Northern Trust first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Edwards Lifesciences position peaked at $878M in Q4 2021.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.